Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing
The Food and Drug Administration (FDA, Agency, or we) is announcing that a proposed collection of in...
Publisher
USA
This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- September 16, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA, Agency, or we) is announcing that a proposed collection of in...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Six neighbourhood health trailblazers to transform care
New neighbourhood health investment partnership to bring care closer to home and tackle health inequ...
Sex ratios at birth in the UK: 2019 to 2023
Analysis of male to female birth ratios in the UK for the period 1 January 2019 to 31 December 2023.
Migrant health: country-of-origin health protection advice
An overview of health protection recommendations, when caring for people who are migrants.
Sex ratios at birth in the UK: 2018 to 2022
Analysis of male to female birth ratios in the UK for the period 1 January 2018 to 31 December 2022.